Results for ''
Research part-funded by HDR UK provided a detailed population-level analysis which was invaluable in guiding vaccine prioritisation decisions.
The HDR UK Impact Commitee selected a paper by Cunningham-Burley et al as the Open Impact Publication of the Month.
Researchers identified and re-analysed a series of studies to assess the reliability of the evidence backing the use of ribavirin as a treatment for Lassa fever.
A team of researchers processed and converted over 1.3 billion rows of UK Biobank data to the Observational Medical Outcomes Partnership (OMOP) common data model (CDM), improving its usability for...
Researchers carried out an analysis of older people and the risk of severe COVID-19 outcomes using the OpenSAFELY research platform
Researchers analysed the primary healthcare records of 7.4 million patients in England to develop a long COVID phenotype, strengthening further research to improve the understanding of the condition.
Researchers have applied machine learning to improve the detection of heart damage through cardiac magnetic resonance (CMR) scans.
EMPA-KIDNEY is an international clinical trial by Oxford Population Health scientists in collaboration with academics spanning eight countries. The study recruited over 6000 participants to...
Large-scale clinical trial shows that a test-and-treat approach to correcting vitamin D deficiency did not reduce risk of COVID-19 or other acute respiratory infections.
